Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Elisavet Paplomata
Addition of Everolimus and Trastuzumab to Endocrine Therapy in Hormone-Refractory Metastatic Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
Related publications
Trastuzumab in the Treatment of Metastatic Breast Cancer : Anticancer Therapy Versus Cardiotoxicity
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Phase II Study of Pembrolizumab and Capecitabine for Triple Negative and Hormone Receptor-Positive, HER2−negative Endocrine-Refractory Metastatic Breast Cancer
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Trastuzumab-Containing Regimens for Metastatic Breast Cancer
Cochrane Database of Systematic Reviews
How to Overcome Endocrine Resistance in Early and Metastatic Breast Cancer
Chronicles of Oncology
Endocrine Therapy of Breast Cancer
HER-2 Testing and Trastuzumab Therapy for Metastatic Breast Cancer: A Cost-Effectiveness Analysis
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
How to Improve Endocrine Therapy of Breast Cancer
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
New Strategies in Metastatic Hormone Receptor–Positive Breast Cancer: Searching for Biomarkers to Tailor Endocrine and Other Targeted Therapies
Clinical Cancer Research
Cancer Research
Oncology
Impact of Adding the Multikinase Inhibitor Sorafenib to Endocrine Therapy in Metastatic Estrogen Receptor-Positive Breast Cancer
Future Oncology
Medicine
Cancer Research
Oncology
